Filtros de búsqueda

Lista de obras de Franco Muggia

"Single"-agent activity of high-dose methotrexate with citrovorum factor rescue

artículo científico publicado en 1978

'BRCAness' and its implications for platinum action in gynecologic cancer

artículo científico publicado en 2014

'Retarded pharmaceuticals' assuming a clinical role

artículo científico publicado en 2004

4'Epidoxorubicin (epirubicin): activity in hepatocellular carcinoma

artículo científico publicado en 1985

5-Azacytidine. A new anticancer drug with effectiveness in acute myelogenous leukemia

artículo científico publicado en 1976

A Phase I/II study of weekly paclitaxel and 3 days of high dose oral estramustine in patients with hormone-refractory prostate carcinoma

artículo científico publicado en 2001

A fixed-ratio combination of uracil and Ftorafur (UFT) with low dose leucovorin. An active oral regimen for advanced colorectal cancer

scientific article published on 01 February 1995

A new look at radionuclides therapy in metastatic disease of bone (review and prospects).

artículo científico publicado en 1988

A pharmacokinetic evaluation of topotecan as a cervical cancer therapy

artículo científico publicado en 2013

A phase 2 study of oxaliplatin combined with continuous infusion topotecan for patients with previously treated ovarian cancer

artículo científico publicado en 2013

A phase I and pharmacokinetic study of docetaxel combined with Doxil (pegylated liposomal doxorubicin) without and with granulocyte colony stimulating factor

artículo científico publicado en 2004

A phase I and pharmacokinetic study of oxaliplatin and bortezomib: activity, but dose-limiting neurotoxicity

artículo científico publicado en 2013

A phase I study of paclitaxel, estramustine phosphate and vinorelbine (Pacl-E-Vin) in advanced malignancies: triple tubulin targeting

artículo científico publicado en 2003

A phase I trial of dose-dense (biweekly) carboplatin combined with paclitaxel and pegfilgrastim: a feasibility study in patients with untreated Stage III and IV ovarian, tubal or primary peritoneal cancer: a Gynecologic Oncology Group study

artículo científico publicado en 2010

A phase I trial of immediate postoperative intraperitoneal floxuridine and leucovorin plus systemic 5-fluorouracil and levamisole after resection of high risk colon cancer

artículo científico publicado en 1995

A phase II study of 13-cis retinoic acid plus interferon alpha-2a in advanced stage penile carcinoma: an Eastern Cooperative Oncology Group study (E3893).

artículo científico publicado en 2003

A phase II study of Doxil (liposomal doxorubicin): lack of activity in poor prognosis soft tissue sarcomas

artículo científico publicado en 1998

A phase II study of bisantrene in advanced refractory breast cancer. An Eastern Cooperative Oncology Group pilot study.

artículo científico publicado en 1985

A phase II study of liposomal lurtotecan (OSI-211) in patients with topotecan resistant ovarian cancer

artículo científico publicado en 2004

A phase II trial of EMD72000 (matuzumab), a humanized anti-EGFR monoclonal antibody, in patients with platinum-resistant ovarian and primary peritoneal malignancies

artículo científico publicado en 2006

A phase II trial of the epothilone B analog ixabepilone (BMS-247550) in patients with metastatic melanoma

artículo científico publicado en 2010

A pilot study of letrozole for one year in women at enhanced risk of developing breast cancer: effects on mammographic density

artículo científico publicado en 2012

A quick method for concentrating and processing cancer cells from serous fluids and fine-needle nodule aspirates

artículo científico publicado en 1977

A randomized multicenter trial of cyclophosphamide, Novantrone and 5-fluorouracil (CNF) versus cyclophosphamide, Adriamycin and 5-fluorouracil (CAF) in patients with metastatic breast cancer

scientific article published on 01 January 1985

A screening and prevention programme serving an ethnically diverse population of women at high risk of developing breast and/or ovarian cancer

artículo científico publicado en 2009

ACCO: ASCO Core Curriculum Outline

scientific article published on 22 February 2005

Abdomino-pelvic hyperthermia and intraperitoneal carboplatin in epithelial ovarian cancer: feasibility, tolerance and pharmacology

artículo científico publicado en 1996

Abstract P2-11-11: Phase II trial of exemestane with immunomodulatory oral cyclophosphamide in metastatic hormone receptor (HR)-positive breast cancer: Prolonged progression-free survival (PFS) in patients with distinct T regulatory cell (Treg) profi

Acid phosphatase levels in bone marrow: value in detecting early bone metastasis from carcinoma of the prostate

scientific article published on 01 April 1970

Activation of complement by therapeutic liposomes and other lipid excipient-based therapeutic products: prediction and prevention

artículo científico publicado en 2011

Activity of anthracyclines in refractory ovarian cancer: recent experience and review

artículo científico publicado en 1997

Activity of daunomycin in solid tumors

scientific article published on 01 October 1976

Activity of epirubicin in pancreatic carcinoma

scientific article published on 01 February 1986

Activity of mitolactol in cancer of the uterine cervix

scientific article published on 01 April 1984

Actual and potential combinations of radiation and chemotherapy with clinical benefits

artículo científico publicado en 1980

Adequacies and inadequacies in assessing murine toxicity data with antineoplastic agents

artículo científico publicado en 1979

Adjuvant chemotherapy in lung cancer: review and prospects

artículo científico publicado en 1977

Adjuvant chemotherapy of testicular carcinoma: need for evaluation of curative strategies

artículo científico publicado en 1978

Adjuvant chemotherapy: correct advice

artículo científico publicado en 1977

Adjuvant systemic therapy of cancer: rationale for future trials

artículo científico publicado en 1978

Adjuvant systemic therapy of lung cancer

artículo científico publicado en 1978

Adjuvant therapy of colon cancer: lessons while looking for breakthroughs

artículo científico publicado en 1991

Adriamycin (NSC-123127) in combination with cyclophosphamide (NSC-26271): a phase I and II evaluation

artículo científico publicado en 1974

Advanced ovarian cancer: three-year results of a 6-8 month, 2-drug cisplatin-containing regimen

artículo científico publicado en 1987

Allopurinol in the treatment of neoplastic disease complicated by hyperuricemia.

artículo científico publicado en 1967

Amino acid manipulations in cancer treatment: a perspective from the National Cancer Institute Workshop.

artículo científico publicado en 1979

An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: An NRG Oncology/Gynecologic Oncology Group experience

artículo científico

Analysis and interpretation of response rates for anticancer drugs

artículo científico publicado en 1979

Animal toxicology for early clinical trials with anticancer agents

artículo científico publicado en 1981

Anthracycline derivatives in new drug development programs

artículo científico publicado en 1979

Anticancer drug development and federal regulation: protection against progress?

artículo científico publicado en 1981

Antitumor activity of pyrazofurin in combination with 5-azacytidine against murine P388 and L1210 leukemias and colon carcinoma 26.

artículo científico publicado en 1979

Apparent myocardial ischemia associated with vinblastine administration.

artículo científico publicado en 1986

Aspects of one-carbon folate cycling related to fluoropyrimidine and antifolate therapy.

artículo científico publicado en 1995

Availability and rational use of essential drugs in the treatment of cancer

scientific article published on 01 November 1985

Azaserine, DON, and azotomycin: three diazo analogs of L-glutamine with clinical antitumor activity

artículo científico publicado en 1979

BRCA genes: lessons learned from experimental and clinical cancer

BRCA mutation status and determinant of outcome in women with recurrent epithelial ovarian cancer treated with pegylated liposomal doxorubicin

artículo científico publicado en 2011

BRCA mutations and outcome in epithelial ovarian cancer (EOC): experience in ethnically diverse groups

artículo científico publicado en 2013

BRCA-deficient animal models and cisplatin resistance

artículo científico publicado en 2009

BRCA1 germline mutation presenting as an adenocarcinoma of unknown primary

Bevacizumab in ovarian cancer: unanswered questions

artículo científico publicado en 2012

Biological modification of protracted infusion of 5-fluorouracil with weekly leucovorin. A dose seeking clinical trial for patients with disseminated gastrointestinal cancers

artículo científico publicado en 1990

Biweekly 72-hour 9-aminocamptothecin infusion as second-line therapy for ovarian carcinoma: phase II study of the New York Gynecologic Oncology Group and the Eastern Cooperative Oncology Group

artículo científico publicado en 2004

Bone-marrow examination in 100 consecutive patients with bronchogenic carcinoma

article by H H Hansen et al published 1 August 1971 in The Lancet

Boosting bioavailability to topotecan: what do we gain?

artículo científico publicado en 2003

Bortezomib: understanding the mechanism of action

scientific article published on 01 November 2011

Brain metastases from choriocarcinoma: two patients illustrating key management issues

artículo científico publicado en 2008

Breast cancer arising in a BRCA-mutated background: therapeutic implications from an animal model and drug development

scientific article published on 15 January 2009

Breast cancer in men. Report illustrating the value of endocrine ablation

scientific article published on 01 October 1974

CA-125 change after chemotherapy in prediction of treatment outcome among advanced mucinous and clear cell epithelial ovarian cancers: a Gynecologic Oncology Group study

artículo científico publicado en 2009

Calvert's formula and high-dose carboplatin

artículo científico publicado en 1994

Camptothecin and its analogs. An overview of their potential in cancer therapeutics

artículo científico publicado en 1996

Camptothecins: a review of their development and schedules of administration

artículo científico publicado en 1998

Cancer and hypercalcemia of malignancy: a change in focus

scientific article published on 01 August 1991

Carboplatin (every 21 days) and divided-dose paclitaxel (days 1, 11): rationale and tolerance in chemotherapy naïve women with high-grade epithelial cancers of Mullerian origin.

artículo científico publicado en 2018

Carboplatin as a radiation sensitizer in locally advanced cervical cancer: a pilot study

artículo científico publicado en 1997

Carboplatin/Paclitaxel Induction in Ovarian Cancer: The Finer Points

scientific article published on 01 August 2018

Carcinoid syndrome from a tumor of Meckel's diverticulum

artículo científico publicado en 1987

Carcinoma of female urethra. Occurrence with hyperparathyroidism

scientific article published on 01 July 1969

Carcinoma of thyroid gland. Associated with systemic amyloidosis and nephrotic syndrome

artículo científico publicado en 1975

Cardiotoxicity of anthracyclines

scientific article published on 01 February 1984

Cell kinetic studies in patients with lung cancer

artículo científico publicado en 1974

Cell kinetic studies in patients with small cell carcinoma of the lung

artículo científico publicado en 1974

Cellular but not plasma pharmacokinetics of lometrexol correlate with the occurrence of cumulative hematological toxicity.

artículo científico publicado en 1998

Challenges posed by non-random missing quality of life data in an advanced-stage colorectal cancer clinical trial

artículo científico publicado en 2000

Characterization of conditions in which dipyridamole enhances methotrexate toxicity in L1210 cells

scientific article published on 01 March 1987

Chemo- and Immunopharmacology: The Reality and the Horizons of Cancer Treatment ⬇️

artículo científico publicado el 1 de enero de 1980

Chemotherapeutic management of carcinoma of the bilharzial bladder: a phase II trial with hexamethylmelamine and VM-26.

artículo científico publicado en 1978

Chemotherapy for locally advanced lung cancer: rationale and issues

artículo científico publicado en 1985

Chemotherapy of alveolar soft part sarcoma: a case report

artículo científico publicado en 1977

Chemotherapy of testicular cancer: from palliation to curative adjuvant therapy

artículo científico publicado en 1979

Chronic aggressive hepatitis--a disorder of desuppression?

artículo científico publicado en 1977

Chronic thalidomide and chemoembolization for hepatocellular carcinoma

artículo científico publicado en 2014

Cis-diamminedichloroplatinum (II). A new anticancer drug

artículo científico publicado en 1977

Cis-diammino-dichloro-platinum therapy of cancers; phase II therapeutic trial

artículo científico publicado en 1979

Cisplatin and irinotecan in squamous cell carcinoma of the cervix: a phase II study of the Gynecologic Oncology Group

artículo científico publicado en 2004

Cisplatin and vinblastine chemotherapy for metastatic non-small cell carcinoma followed by irradiation in patients with regional disease

artículo científico publicado en 1986

Cisplatin update

artículo científico publicado en 1991

Cisplatin with capecitabine: tolerance and activity in a phase I/II study preferentially enrolling patients with gastric cancer

artículo científico publicado en 2012

Cisplatin-DNA damage and repair in peripheral blood leukocytes in vivo and in vitro

artículo científico publicado en 1992

Cisplatin: impact of a new anticancer agent on current therapeutic strategies

artículo científico publicado en 1981

Cisplatinumdiamminodichloride (CPDD) in chemotherapy of cancers: a phase II therapeutic trial

artículo científico publicado en 1980

Clinical Drug Development in 2012 ⬇️

artículo científico publicado el 1 de junio de 2012

Clinical Evaluation of New Antitumor Antibiotics ⬇️

artículo científico publicado el 1 de enero de 1978

Clinical Trials of Hyperthermic Intraperitoneal Chemotherapy in Advanced Ovarian Cancer: Unanswered Questions.

artículo científico publicado en 2015

Clinical development of topoisomerase-interactive drugs.

artículo científico publicado en 1994

Clinical efficacy and prospects for use of pegylated liposomal doxorubicin in the treatment of ovarian and breast cancers

artículo científico publicado en 1997

Clinical features of taxane neuropathy

artículo científico publicado en 2014

Clinical implications of cisplatin pharmacology

artículo científico publicado en 1980

Clinical studies with 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC 79037).

artículo científico publicado en 1971

Clinical studies with a new podophyllotoxin derivative, epipodophyllotoxin, 4'-demethyl-9-(4,6-O-2-thenylidine- -D-glucopyranoside) (NSC-122819).

artículo científico publicado en 1971

Clinical study with bleomycin: tolerance to twice weekly dosage.

artículo científico publicado en 1972

Clinical trials in cancer: general concepts and methodologies

artículo científico publicado el 1 de enero de 1978

Clinical trials with diglycoaldehyde (NSC-118994): review and reasons for withdrawal from clinical trial.

artículo científico publicado en 1981

Clinical trials with the hexitol derivatives in the U.S.

artículo científico publicado en 1981

Closing the loop: providing feedback on drug development

artículo científico publicado en 1987

Co-existence of breast and ovarian cancers in BRCA germ-line mutation carriers

artículo científico publicado en 2008

Colorectal cancer: speculations on the role of intraperitoneal therapy

artículo científico publicado en 1985

Combination chemotherapy containing semustine (MeCCNU) in patients with advanced colorectal cancer previously treated with 5-fluorouracil (5-Fu)

scientific article published on 01 April 1983

Combination chemotherapy of advanced colorectal cancer utilizing 5-fluorouracil, semustine, dacarbazine, vincristine, and hydroxyurea: a phase III trial by the Eastern Cooperative Oncology Group (EST: 4275).

artículo científico publicado en 1982

Comments on the carcinogenic, mutagenic, and teratogenic properties of anticancer drugs.

artículo científico publicado en 1980

Complement activation by Cremophor EL as a possible contributor to hypersensitivity to paclitaxel: an in vitro study

artículo científico publicado en 1998

Complement activation following first exposure to pegylated liposomal doxorubicin (Doxil): possible role in hypersensitivity reactions

artículo científico publicado en 2003

Completion rates of adjuvant chemotherapy for colon cancer: a historical perspective

artículo científico publicado en 2006

Conclusions: fruits of the convergence of laboratory, clinic and public

artículo científico publicado en 2011

Concurrent radiotherapy, paclitaxel and dose escalating carboplatin in the treatment of cervical cancer--a phase I study

scientific article published on 01 September 2008

Constrictive pericarditis following radiation therapy

artículo científico publicado en 1968

Continued erlotinib maintenance and salvage radiation for solitary areas of disease progression: a useful strategy in selected non-small cell lung cancers?

artículo científico publicado en 2013

Continuous-infusion topotecan and erlotinib: a study in topotecan-pretreated ovarian cancer assessing shed collagen epitopes as a marker of invasiveness

scientific article published on 21 February 2014

Correlation between in vitro labeling indices (LIs) and tumor regression following radiotherapy

artículo científico publicado en 1978

Correlation of histologic types with cell kinetic studies in lung cancer

artículo científico publicado el 1 de marzo de 1973

Correlation of p53 immunostaining in primary and residual ovarian cancer at the time of positive second-look laparotomy and its prognostic role: a Southwest Oncology Group ancillary study

artículo científico publicado en 2002

Creatine phosphokinase and other serum enzymes during radiotherapy. Comparison of cardiac vs noncardiac irradiation

scientific article published on 01 February 1970

Critical complications in patients with cancer: prevention and treatment

artículo científico

Current adjuvant trials in colorectal cancer

artículo científico publicado en 1979

Current cooperative clinical trials in the non-Hodgkin's lymphomas

artículo científico publicado en 1977

Current results of the screening program at the Division of Cancer Treatment, National Cancer Institute

scientific article published on 01 February 1981

Current trends and prospects in surgical adjuvant trials

artículo científico publicado en 1978

Cyclophosphamide and CCNU in the treatment of inoperable small cell carcinoma and adenocarcinoma of the lung

artículo científico publicado en 1976

Cyclophosphamide and the urinary bladder

artículo científico publicado en 1971

Cytembena: an anticancer drug with an unique structure

artículo científico publicado en 1977

Cytoprotection: concepts and challenges

artículo científico publicado en 1994

Cytoprotection: shelter from the storm

artículo científico publicado en 1999

Cytotoxic drug-induced pulmonary disease: update 1980.

artículo científico publicado en 1980

Daunomycin-induced cardiotoxicity in children and adults. A review of 110 cases

artículo científico publicado en 1977

De novo Kaposi's sarcoma in renal transplantation. Case report and brief review

artículo científico publicado en 1976

Decreasing Trends of Secondary Primary Colorectal Cancer among Women with Uterine Cancer: A Population-Based Analysis.

artículo científico publicado en 2019

Decreasing secondary primary uterine cancer after breast cancer: A population-based analysis

artículo científico publicado en 2019

Defining risks of taxane neuropathy: insights from randomized clinical trials.

artículo científico

Delayed neoplastic and renal complications in women receiving long-term chemotherapy for recurrent ovarian cancer

scientific article published on 29 November 2010

Description of an emerging epidemic: the acquired immunodeficiency syndrome (AIDS).

artículo científico publicado en 1983

Determination of hydroxyurea in plasma and peritoneal fluid by high-performance liquid chromatography using electrochemical detection

artículo científico publicado en 1997

Development of tumor-infiltrating lymphocytes in breast cancer after neoadjuvant paclitaxel chemotherapy

Diagnosis of liver metastases in bronchogenic carcinoma. A comparative study of liver scans, function tests, and peritoneoscopy with liver biopsy in 111 patients

artículo científico publicado en 1974

Documentation of complete response in metastatic breast cancer to liver and bone achieved with trastuzumab and pegylated liposomal Doxorubicin

artículo científico publicado en 2008

Dose intensity: not the only path to clinical dose optimization

scientific article published on 01 January 1996

Dose-escalation study of carboplatin (day 1) and cisplatin (day 3): tolerance and relation to leukocyte and buccal cell platinum--DNA adducts

artículo científico publicado en 1991

Down's syndrome and testicular cancer: a possible association

artículo científico publicado en 1985

Doxil in breast cancer ⬇️

artículo científico publicado el 1 de febrero de 1998

Doxil-induced radiation recall: a cause for false-positive PET scan findings

artículo científico publicado en 2001

Doxorubicin and interferon: rationale and clinical experience

artículo científico publicado en 1985

Doxorubicin for metastatic breast cancer: time for a change?

scientific article published on 01 January 2003

Doxorubicin-cyclophosphamide: effective chemotherapy for advanced endometrial adenocarcinoma.

artículo científico publicado en 1977

Doxorubicin-induced cardiomyopathy

artículo científico publicado en 1999

Doxorubicin-polymer conjugates: further demonstration of the concept of enhanced permeability and retention

artículo científico publicado en 1999

Drug-induced DNA modification in buccal cells of cancer patients receiving carboplatin and cisplatin combination chemotherapy, as determined by an immunocytochemical method: interindividual variation and correlation with disease response.

artículo científico publicado en 1993

Early detection of bone-marrow invasion in oat-cell carcinoma of the lung

artículo científico publicado en 1971

Ectopic placental proteins in nontrophoblastic tumors. Serial measurements following chemotherapy

artículo científico publicado en 1975

Effective adjuvant treatments. A brief review of U.S. clinical trials

artículo científico publicado en 1978

Efficacy and safety of liposomal anthracyclines in phase I/II clinical trials

artículo científico publicado en 2004

Efficacy of 6-diazo-5-oxo-L-norleucine and N-[N-gamma-glutamyl-6-diazo-5-oxo-norleucinyl]-6-diazo-5-oxo-norleucine against experimental tumors in conventional and nude mice

artículo científico publicado en 1979

Efficacy of pegylated liposomal doxorubicin maintenance therapy in platinum-sensitive recurrent epithelial ovarian cancer: a retrospective study

scientific article published on 01 March 2019

Emerging treatments for ovarian cancer

artículo científico publicado en 2003

Endocrine-responsive breast cancer: a 28-year Odyssey

artículo científico publicado en 2011

Endometrial adenocarcinoma presenting as a suprasellar mass: lessons to be learned

scientific article published on 31 July 2020

Endometrial carcinoma with cerebellar metastasis: a case report and review of the literature

artículo científico publicado en 2002

Eosinophilia following radiation therapy

scientific article published on 01 January 1973

Epidermal growth factor receptor inhibitors for the treatment of epithelial ovarian cancer.

artículo científico publicado en 2005

Epipodophyllotoxins: new laboratory and clinical findings.

artículo científico publicado en 1989

Erlotinib added to carboplatin and paclitaxel as first-line treatment of ovarian cancer: a phase II study based on surgical reassessment.

artículo científico publicado en 2010

Estramustine phosphate: a specific chemotherapeutic agent?.

artículo científico publicado en 1977

Estramustine potentiates taxane in prostate and refractory breast cancers

artículo científico publicado en 2001

European Organization for Research and Treatment of Cancer Workshop. Problems and prospects in current therapeutic application of molecular biology

artículo científico publicado en 1987

Evaluation of a sequential 5-FU and hydroxyurea combination in advanced bowel cancer

scientific article published on 01 November 1984

Evaluation of fludarabine phosphate in malignant melanoma. A Southwest Oncology Group study

scientific article published on 01 February 1991

Evaluation of vinorelbine in persistent or recurrent nonsquamous carcinoma of the cervix: a Gynecologic Oncology Group Study

artículo científico publicado en 2005

Evaluation of vinorelbine in persistent or recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study

artículo científico publicado en 2004

Evidence of the selective alteration of anthracycline activity due to modulation by ICRF-187 (ADR-529).

artículo científico publicado en 1990

Exploratory laparotomy in reticulum cell sarcoma. A retrospective analysis

artículo científico publicado en 1972

Ezra Greenspan: a trailblazer in combination chemotherapy

artículo científico publicado en 2005

Failure of pretreatment with intravenous folic acid to alter the cumulative hematologic toxicity of lometrexol

scientific article published on 01 October 1996

Familial breast cancer screening: ethical and social implications

artículo científico publicado en 2004

Fatal hepatitis B reactivation due to everolimus in metastatic breast cancer: case report and review of literature.

artículo científico

Feasibility and cardiac safety of pegylated liposomal doxorubicin plus trastuzumab in heavily pretreated patients with recurrent HER2-overexpressing metastatic breast cancer

scientific article published on 01 August 2007

Five years of adjuvant treatment of osteosarcoma: more questions than answers

artículo científico publicado en 1978

Future clinical investigations with anthracycline antibiotics in relation to daunorubicin

artículo científico publicado en 1981

Future of cancer chemotherapy with cisplatin

artículo científico

Gemcitabine plus cisplatin combination given with amifostine (GAP) to heavily pretreated patients with gynecologic and peritoneal cancers: tolerance and activity in ovarian cancer

artículo científico publicado en 1998

General progress in clinical chemotherapy of advanced disease

artículo científico publicado en 1980

Glomerulonephritis or nephrotic syndrome in malignant lymphoma, reticulum-cell type.

artículo científico publicado en 1971

Good tolerance of weekly oral idarubicin: (4-demethoxydaunorubicin): a phase I study with pharmacology

artículo científico publicado en 1990

Gynecologic manifestations of reticulum cell sarcoma

artículo científico publicado en 1968

HE4: another 'player' in the epithelial tumor marker arena?

artículo científico publicado en 2013

Heidelberger symposium on the 50th anniversary of fluoropyrimidines

artículo científico publicado en 2009

Hemorrhagic necrosis of the intestine: its occurrence with digitalis intoxication

artículo científico publicado en 1967

Hepatotoxicity of combination chemotherapy for acute myelocytic leukemia

scientific article published on 01 August 1977

Hereditary breast and ovarian cancer: lessening the burden

artículo científico publicado en 2013

Hereditary breast and ovarian cancer: risks and challenges. 10-12 September 2009: Bari, Italy. Introduction

artículo científico publicado en 2011

Hexamethylmelamine in platinum-resistant ovarian cancer: how active?

artículo científico publicado en 1992

High dose intensity of cisplatin and etoposide in adenocarcinoma of unknown primary.

artículo científico publicado en 1991

High incidence of coagualopathy in phase II studies of recombinant tumor necrosis factor in advanced pancreatic and gastric cancers.

artículo científico publicado en 1992

High-dose chemotherapy and autologous bone marrow plus peripheral blood stem cell transplantation for patients with lymphoma or metastatic breast cancer: use of marker genes to investigate hematopoietic reconstitution in adults

artículo científico publicado en 1996

High-dose methotrexate, not a conventional treatment

scientific article published on 01 January 1978

High-dose toremifene as a cisplatin modulator in metastatic non-small cell lung cancer: targeted plasma levels are achievable clinically

artículo científico publicado en 1998

High-performance liquid chromatographic method for the determination of a novel thymidylate synthase inhibitor, AG 331, in human serum.

artículo científico publicado en 1995

Hormonal management of breast cancer

artículo científico publicado en 1969

Hormonal therapy of breast cancer: new approaches and concepts

artículo científico publicado en 1978

How to improve survival after diagnosis of gastric cancer? It's back to the drawing board

artículo científico publicado en 1993

Hypercalcemia associated with neoplastic disease

scientific article published on 01 August 1970

Hypercalcemia in cancer

artículo científico publicado en 1970

Hypercalcemia in epidermoid tumors of the head and neck and esophagus

scientific article published on 01 June 1973

Hyperkalaemia and chemotherapy

ICRF-159: current status and clinical prospects

scientific article published on 01 November 1977

ICRF-187 (ADR-529) cardioprotection against anthracycline-induced cardiotoxicity: clinical and preclinical studies

artículo científico publicado en 1991

Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathological stage II testicular cancer

artículo científico publicado en 1987

Immune modulating therapy in gastrointestinal cancer

artículo científico

Immune modulation and cancer control

artículo científico publicado en 1978

Immunological profile of breast cancer patients in early or advanced disease

artículo científico publicado en 1979

Immunotherapy of lung cancer. I. Review of clinical trials in non-small cell histologic types

artículo científico publicado en 1979

Immunotherapy of lung cancer. II. Review of clinical trials in small cell carcinoma

artículo científico publicado en 1979

Improved quality of life of patients with small-cell carcinoma of the lung by elective irradiation of the brain

artículo científico publicado en 1983

In Memoriam: Umberto Veronesi (1925-2016)

artículo científico publicado en 2017

In vivo tumor cell kinetic studies: use of local thymidine injection followed by fine-needle aspiration

artículo científico publicado en 1972

Inhibition of Ovarian Tumor Growth by Targeting the HU177 Cryptic Collagen Epitope

artículo científico publicado en 2016

Intensive combined chemotherapy and radiotherapy in patients with nonresectable bronchogenic carcinoma

artículo científico publicado en 1972

International activities of the Division of Cancer Treatment, National Cancer Institute.

artículo científico publicado en 1979

Intra-abdominal carcinomatosis with histologically normal ovaries

artículo científico publicado en 1984

Intraarterial chemotherapy of head and neck cancer: worth another look?

artículo científico publicado en 1980

Intraperitoneal 5-fluoro-2'-deoxyuridine (FUDR) and (S)-leucovorin for disease predominantly confined to the peritoneal cavity: a pharmacokinetic and toxicity study

artículo científico publicado en 1995

Intraperitoneal 5-fluoro-2'-deoxyuridine with escalating doses of leucovorin: pharmacology and clinical tolerance

artículo científico publicado en 1994

Intraperitoneal Therapy for Ovarian Cancer

scientific article published on 01 February 2016

Intraperitoneal carboplatin and etoposide for persistent epithelial ovarian cancer: analysis of results by prior sensitivity to platinum-based regimens.

artículo científico publicado en 1993

Intraperitoneal carboplatin: favorable results in women with minimal residual ovarian cancer after cisplatin therapy

artículo científico publicado en 1990

Intraperitoneal chemotherapy: technical experience at five institutions

Intraperitoneal drug delivery for ovarian cancer: why, how, who, what, and when?

artículo científico publicado en 2011

Intraperitoneal mitoxantrone or floxuridine: effects on time-to-failure and survival in patients with minimal residual ovarian cancer after second-look laparotomy--a randomized phase II study by theSouthwest Oncology Group.

artículo científico publicado en 1996

Intraperitoneal therapy as consolidation for patients with ovarian cancer and negative reassessment after platinum-based chemotherapy.

artículo científico publicado en 2003

Intraperitoneal therapy for ovarian cancer: analysis of fluid distribution by computerized tomography

artículo científico publicado en 1992

Intraperitoneal therapy for stage III ovarian cancer: a therapy whose time has come!

artículo científico publicado en 2002

Intraperitoneal therapy in ovarian cancer: time's not up

scientific article published on 01 August 1991

Intraperitoneal topoisomerase-I inhibitors. Preliminary findings with 9-aminocamptothecin.

artículo científico publicado en 2000

Introduction: why a supplement on taxanes?

artículo científico publicado en 2014

Investigational agents for epithelial ovarian cancer

artículo científico publicado en 2005

Investigational chemotherapeutic agents in head and neck cancer

artículo científico publicado en 1977

Irradiated lung cancer. An autopsy analysis of spread pattern

artículo científico publicado en 1975

Is renal thrombotic angiopathy an emerging problem in the treatment of ovarian cancer recurrences?

artículo científico publicado en 2012

Kaposi's sarcoma and AIDS.

artículo científico publicado en 1986

Kaposi's sarcoma: a new staging classification.

artículo científico publicado en 1983

Lasting pathologic complete response to chemotherapy for ovarian cancer after receiving antimalarials for dermatomyositis.

artículo científico publicado en 2018

Lethal and sublethal effects of the combination of doxorubicin and the bisdioxopiperazine, (+)-1,2,-bis (3-5-dioxopiperazinyl-1-yl) propane (ICRF 187), on murine sarcoma S180 in vitro

artículo científico publicado en 1987

Letter: Allergic reactions to cis platinum

artículo científico publicado en 1976

Letter: Antiestrogens in the treatment of cancer

artículo científico publicado en 1976

Letter: Ectopic production of calcitonin

artículo científico publicado en 1973

Letter: Treatment of "pancreatic cholera".

artículo científico publicado en 1975

Letter: Treatment of small-cell carcinoma of bronchus

artículo científico publicado en 1975

Liposomal anthracycline treatment for ovarian cancer

artículo científico publicado en 2004

Liposomal doxorubicin: antitumor activity and unique toxicities during two complementary phase I studies.

artículo científico publicado en 1995

Liposomal encapsulated anthracyclines: new therapeutic horizons

artículo científico publicado en 2001

Long-term sequelae of cancer chemotherapy

artículo científico publicado en 1980

Long-term survivors with small cell carcinoma of the lung

artículo científico publicado en 1980

Loss of p27KIP1 expression in fully-staged node-negative breast cancer: association with lack of hormone receptors in T1a/b, but not T1c infiltrative ductal carcinoma.

artículo científico publicado en 2011

Low doses of dexamethasone protect against paclitaxel (Taxol)-related hypersensitivity reactions following cycle 1

scientific article published on 01 May 1994

Lung cancer. Chemotherapy as curative treatment

scientific article published on 01 May 1981

Lung cancer: diagnosis in metastatic sites

artículo científico publicado en 1974

Lysozymuria and renal tubular dysfunction in monocytic and myelomonocytic leukemia

scientific article published on 01 September 1969

MDR1 gene expression in primary and advanced breast cancer.

artículo científico publicado en 1999

Maintenance chemotherapy in advanced ovarian cancer

artículo científico publicado en 2000

Malignancies in the acquired immunodeficiency syndrome

artículo científico publicado en 1987

Malignant mesothelioma of the tunica vaginalis testis

artículo científico publicado en 1984

Management of peritoneal carcinomatosis of unknown primary tumor site

artículo científico publicado en 1993

Managing breast cancer in an outpatient setting

artículo científico publicado en 1992

Mechanisms of proteasome inhibitor PS-341-induced G(2)-M-phase arrest and apoptosis in human non-small cell lung cancer cell lines.

artículo científico publicado en 2003

Meeting Report: Hereditary Breast and Ovarian Cancer (HBOC): Risks and Challenges. September 10-12, 2009 Bari, Italy

article

Megaloblastic anemia associated with parenchymal hemosiderosis

artículo científico publicado en 1967

Methodology for the assessment of new dichotomous diagnostic tests.

artículo científico publicado en 1981

Methodology phase II clinical trial in cancer

artículo científico publicado en 1980

Mismatch repair status and clinical outcome in endometrial cancer: a systematic review and meta-analysis.

artículo científico publicado en 2013

Mitomycin and methotrexate: negative experience in untreated colorectal carcinoma

artículo científico publicado en 1985

Monoclonal antibody therapy in intra-abdominal malignancies.

artículo científico publicado en 1990

Moral dilemmas in clinical cancer experimentation

artículo científico publicado en 1978

More on intraperitoneal therapy

scientific article published on 01 September 1994

More on intraperitoneal therapy

scientific article published on 07 September 2006

Mouse and large-animal toxicology studies of twelve antitumor agents: relevance to starting dose for phase I clinical trials

artículo científico publicado en 1979

Mucinous cancer of the appendix: challenges in diagnosis and treatment

scientific article published on 01 August 2007

Multidisciplinary considerations in cancer treatment: origin and scope

artículo científico publicado en 1984

N-(Phosphonacetyl)-L-aspartate (PALA): current status

scientific article published on 01 January 1980

N-Acetylcysteine (NAC): a significant chemoprotective adjunct. Introduction

artículo científico publicado en 1983

Nanoparticle albumin-bound paclitaxel (nab-paclitaxel): extending its indications

artículo científico publicado en 2014

Neoadjuvant chemotherapy in patients with advanced endometrial cancer

scientific article published on 12 April 2019

Neoadjuvant chemotherapy with CPT-11 and cisplatin downstages locally advanced gastric cancer

artículo científico publicado en 2002

Neoadjuvant chemotherapy, surgery, and adjuvant intraperitoneal chemotherapy in patients with locally advanced gastric or gastroesophageal junction carcinoma: a phase II study

artículo científico publicado en 2005

Neuropathic fracture. Unusual complication in a patient with advanced diabetic neuropathy

scientific article published on 01 January 1965

New and emerging intraperitoneal (IP) drugs for ovarian cancer treatment

artículo científico publicado en 2006

New anthracycline antitumor antibiotics

artículo científico publicado en 1991

New anticancer drugs

scientific article published on 01 January 1978

New chemotherapies for ovarian cancer. Systemic and intraperitoneal podophyllotoxins

artículo científico publicado en 1991

No evidence of acute cardiovascular complications of chemotherapy for testicular cancer: an analysis of the Testicular Cancer Intergroup Study

artículo científico publicado en 1992

Nomogram for Predicting Individual Survival After Recurrence of Advanced-Stage, High-Grade Ovarian Carcinoma

article

Noninvasive monitoring of drug biodistribution and metabolism: studies with intraarterial Pt-195m-cisplatin in humans

artículo científico publicado en 1989

Novel neurosensory testing in cancer patients treated with the epothilone B analog, ixabepilone

artículo científico publicado en 2008

Novel taxanes

artículo científico

Novel therapies delay the progression of smoldering multiple myeloma: Case report and discussion

artículo científico publicado en 2010

Nucleoside and nucleobase analogs in cancer treatment: not only sapacitabine, but also gemcitabine.

artículo científico publicado en 2012

OSLER'S DISEASE WITH AN AORTIC ARCH ANEURYSM; REPORT OF A CASE

artículo científico publicado en 1964

OSTEOGENIC SARCOMA OF THE ILIUM; REPORT OF A CASE ASSOCIATED WITH OSTEOBLASTIC PROSTATIC ADENOCARCINOMA

artículo científico publicado en 1965

Observations on the human pharmacology of cycloleucine

artículo científico publicado en 1977

Oral 4-demethoxydaunorubicin (idarubicin) in bronchogenic lung cancer; phase II trial

scientific article published on 01 January 1986

Oral Squamous Cell Carcinoma as a Complication of Treatment for Recurrent High-Grade Serous Cancer

scientific article published on 04 December 2019

Original p53 status predicts for pathological response in locally advanced breast cancer patients treated preoperatively with continuous infusion 5-fluorouracil and radiation therapy

artículo científico publicado en 1997

Osteoblastic metastases in small-cell (oat-cell) carcinoma of the lung

artículo científico publicado en 1972

Ovarian cancer in BRCA mutation carriers: improved outcome after intraperitoneal (IP) cisplatin

artículo científico publicado en 2013

Ovarian cancer: a brief historical overview of intraperitoneal trials

artículo científico publicado en 2013

Ovarian cancer: new therapeutic concepts, renewed optimism

artículo científico publicado en 1985

Overview of cancer-related hypercalcemia: epidemiology and etiology

artículo científico publicado en 1990

Overview of carboplatin: replacing, complementing, and extending the therapeutic horizons of cisplatin

artículo científico

Overview of early and investigational chemotherapeutic agents in solid tumors

artículo científico publicado en 1976

Oxaliplatin with weekly bolus fluorouracil and low-dose leucovorin as first-line therapy for patients with colorectal cancer

artículo científico publicado en 2003

PS-341, a novel proteasome inhibitor, induces Bcl-2 phosphorylation and cleavage in association with G2-M phase arrest and apoptosis

artículo científico publicado en 2002

Paclitaxel (Taxol) in heavily pretreated ovarian cancer: antitumor activity and complications

artículo científico publicado en 1994

Paclitaxel 3-hour infusion given alone and combined with carboplatin: preliminary results of dose-escalation trials

artículo científico publicado en 1995

Paclitaxel plus oxaliplatin for recurrent or metastatic cervical cancer: a New York Cancer Consortium Study

artículo científico publicado en 2009

Paclitaxel-Carboplatin Doublets-More Finer Points to Learn

artículo científico publicado en 2020

Paclitaxel-induced apoptosis and mitotic arrest assessed by serial fine-needle aspiration: implications for early prediction of breast cancer response to neoadjuvant treatment

artículo científico publicado en 2000

Pancreatic cancer: a new target for adjuvant therapy and chemotherapy

Paraneoplastic hypercalcemia in clear cell ovarian adenocarcinoma

artículo científico publicado en 2012

Patterns of hematologic toxicities from anticancer drugs

artículo científico publicado en 1983

Pegylated liposomal doxorubicin (PLD): enhanced skin toxicity in areas of vitiligo.

artículo científico publicado en 2008

Pegylated liposomal doxorubicin (doxil): reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg/m2.

artículo científico publicado en 2000

Pegylated liposomal doxorubicin HCL (PLD; Caelyx/Doxil): experience with long-term maintenance in responding patients with recurrent epithelial ovarian cancer.

artículo científico publicado en 2007

Pegylated liposomal doxorubicin and renal thrombotic microangiopathy: an under-recognized complication of prolonged treatment for ovarian cancer

artículo científico publicado en 2014

Peripheral blood mononuclear and tumor cell pharmacodynamics of the novel epothilone B analogue, ixabepilone

artículo científico publicado en 2006

Pharmacodynamics of tubulin and tubulin-binding agents: extending their potential beyond taxanes.

artículo científico publicado en 2008

Phase 1 trial of intraperitoneal AD-32 in gynecologic malignancies

artículo científico publicado en 1996

Phase 1/pharmacology study of intraperitoneal topotecan alone and with cisplatin: potential for consolidation in ovarian cancer

artículo científico publicado en 2010

Phase I and pharmacokinetic study of oral UFT, a combination of the 5-fluorouracil prodrug tegafur and uracil.

artículo científico publicado en 1996

Phase I and pharmacokinetic study of veliparib, a PARP inhibitor, and pegylated liposomal doxorubicin (PLD) in recurrent gynecologic cancer and triple negative breast cancer with long-term follow-up

artículo científico publicado en 2020

Phase I and pharmacologic evaluation of intraperitoneal 5-fluoro-2'-deoxyuridine

artículo científico publicado en 1991

Phase I and pharmacologic study of estramustine phosphate and short infusions of paclitaxel in women with solid tumors

artículo científico publicado en 1998

Phase I and pharmacologic study of i.p. 9-aminocamptothecin given as six fractions over 14 days

artículo científico publicado en 2002

Phase I and pharmacologic study of i.v. hydroxyurea infusion given with i.p. 5-fluoro-2'-deoxyuridine and leucovorin

artículo científico publicado en 2001

Phase I and pharmacologic study of liposomal daunorubicin (DaunoXome).

artículo científico publicado en 1994

Phase I clinical and pharmacokinetic study of BMS-247550, a novel derivative of epothilone B, in solid tumors

artículo científico publicado en 2004

Phase I clinical study of infusional 5-fluorouracil with oxaliplatin and gemcitabine (FOG regimen) in patients with solid tumors

artículo científico publicado en 2003

Phase I clinical trial of 9,10-anthracene dicarboxaldehyde (Bisantrene) administered in a five-day schedule

artículo científico publicado en 1982

Phase I clinical trial of isophosphamide (NSC-109724)

artículo científico publicado en 1975

Phase I clinical trial of weekly and daily treatment with camptothecin (NSC-100880): correlation with preclinical studies.

artículo científico publicado en 1972

Phase I study of (6R)-5,10-dideazatetrahydrofolate: a folate antimetabolite inhibitory to de novo purine synthesis

artículo científico publicado en 1993

Phase I study of AG 331, a novel thymidylate synthase inhibitor, in patients with refractory solid tumors

artículo científico publicado en 1999

Phase I study of amifostine as a cytoprotector of the gemcitabine/cisplatin combination in patients with advanced solid malignancies

artículo científico publicado en 2003

Phase I study of bryostatin 1, a protein kinase C modulator, preceding cisplatin in patients with refractory non-hematologic tumors

scientific article published on 17 February 2009

Phase I study of combined pegylated liposomal doxorubicin with protracted daily topotecan for ovarian cancer

artículo científico publicado en 2005

Phase I toxicity and pharmacology study of trimethylcolchicinic acid in patients with advanced malignancies

artículo científico publicado en 1990

Phase I trial of escalating dose doxorubicin administered concurrently with alpha 2-interferon.

artículo científico publicado en 1988

Phase I trial of paclitaxel and etoposide for recurrent ovarian carcinoma: a Gynecologic Oncology Group Study

artículo científico publicado en 2000

Phase I-II study of the continuous infusion of doxorubicin in the treatment of non-small cell lung cancer

scientific article published on 01 April 1984

Phase I/II Trial of Thymostimulin in Opportunistic Infections of the Acquired Immune Deficiency Syndrome

scientific article published on 01 January 1989

Phase I/II clinical and pharmacokinetic evaluation of liposomal daunorubicin

artículo científico publicado en 1995

Phase I/II study of intraperitoneal floxuridine and platinums (cisplatin and/or carboplatin).

artículo científico publicado en 1997

Phase II clinical trial of carboplatin, ifosfamide, with oral mesna for metastatic breast carcinoma

artículo científico publicado en 1995

Phase II studies of recombinant human tumor necrosis factor alpha in patients with malignant disease: a summary of the Southwest Oncology Group experience

artículo científico publicado en 1991

Phase II study of bevacizumab with liposomal doxorubicin for patients with platinum- and taxane-resistant ovarian cancer.

artículo científico publicado en 2012

Phase II study of combination taxol and estramustine phosphate in the treatment of recurrent glioblastoma multiforme.

artículo científico publicado en 2000

Phase II study of darinaparsin in patients with advanced hepatocellular carcinoma.

artículo científico publicado en 2009

Phase II study of esorubicin (4'deoxydoxorubicin) in anthracycline naive patients with ovarian cancer

artículo científico publicado en 1990

Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group study

artículo científico publicado en 1995

Phase II study of irinotecan in combination with bevacizumab in recurrent ovarian cancer.

artículo científico publicado en 2016

Phase II study of liposomal cisplatin (SPI-77) in platinum-sensitive recurrences of ovarian cancer

scientific article published on 01 February 2010

Phase II study of liposomal doxorubicin in advanced gynecologic cancers

artículo científico publicado en 2000

Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation.

artículo científico publicado en 1997

Phase II study of mitoxantrone in advanced breast cancer: an Eastern Cooperative Oncology Group pilot study

scientific article published on 01 December 1984

Phase II study of oral idarubicin in patients with AIDS-associated Kaposi's sarcoma

artículo científico publicado en 1987

Phase II trial of Baker's antifol in patients with recurrent or inoperable head and neck cancer

artículo científico publicado en 1986

Phase II trial of ICRF-187 in patients with acquired immune deficiency related Kaposi's sarcoma (AIDS-KS).

artículo científico publicado en 1989

Phase II trial of PALA in lymphoma: an Eastern Cooperative Oncology Group study

artículo científico publicado en 1984

Phase II trial of PCNU in advanced malignant melanoma: an Eastern Cooperative Oncology Group pilot study

artículo científico publicado en 1985

Phase II trial of RAD001 plus carboplatin in patients with triple-negative metastatic breast cancer

Phase II trial of carboplatin and infusional cyclosporine in platinum-resistant recurrent ovarian cancer

artículo científico publicado en 2004

Phase II trial of carboplatin and infusional cyclosporine with alpha-interferon in recurrent ovarian cancer: a California Cancer Consortium Trial.

artículo científico publicado en 2007

Phase II trial of carboplatin or iproplatin in cervical cancer

artículo científico publicado en 1991

Phase II trial of cyclophosphamide and cis-platinum for non-small cell bronchogenic carcinoma

scientific article published on 01 December 1984

Phase II trial of dacarbazine and thalidomide for the treatment of metastatic melanoma

artículo científico publicado en 2009

Phase II trial of oral methotrexate and dipyridamole in colorectal carcinoma

artículo científico publicado en 1987

Phase II trial of pembrolizumab in combination with nab-paclitaxel in patients with metastatic HER2-negative breast cancer

Phase II trial of the combination of bryostatin-1 and cisplatin in advanced or recurrent carcinoma of the cervix: a New York Gynecologic Oncology Group study

artículo científico publicado en 2004

Phase II trial of the pegylated liposomal doxorubicin in previously treated metastatic endometrial cancer: a Gynecologic Oncology Group study

artículo científico publicado en 2002

Phase II trials: use of a clinical tumor panel and overview of current resources and studies

artículo científico publicado en 1980

Phase III data on Caelyx in ovarian cancer

artículo científico publicado en 2001

Phase III randomized study of cisplatin versus paclitaxel versus cisplatin and paclitaxel in patients with suboptimal stage III or IV ovarian cancer: a gynecologic oncology group study

artículo científico publicado en 2000

Plasma camptothecin (NSC-100880) levels during a 5-day course of treatment: relation to dose and toxicity.

artículo científico publicado en 1972

Plasma carcinoembryonic antigen as an indicator of cerebral metastases

artículo científico publicado en 1990

Platinum Antitumor Complexes: 50 Years Since Barnett Rosenberg's Discovery

artículo científico publicado en 2015

Platinum and other heavy metal coordinating compounds in cancer chemotherapy: overview of Verona ISPCC XI

Platinum compounds 30 years after the introduction of cisplatin: implications for the treatment of ovarian cancer

artículo científico publicado en 2008

Platinum compounds in cervical and endometrial cancers: focus on carboplatin

artículo científico publicado en 1994

Platinum resistance. Experimental and clinical status.

artículo científico publicado en 1994

Platinum resistance: laboratory findings and clinical implications

artículo científico publicado en 1993

Platinum type is key in determining degree of neuropathy

artículo científico publicado en 2018

Platinum-DNA adduct in leukocyte DNA of a cohort of 49 patients with 24 different types of malignancies

scientific article published on 01 August 1993

Platinum-DNA damage in leukocyte DNA of patients receiving carboplatin and cisplatin chemotherapy, measured by atomic absorption spectrometry

artículo científico publicado en 1991

Platinums: extending their therapeutic spectrum

artículo científico publicado en 2004

Pleural mesothelioma: clinical features and therapeutic implications

artículo científico publicado en 1977

Postoperative intraperitoneal 5-fluoro-2'-deoxyuridine added to chemoradiation in patients curatively resected (R0) for locally advanced gastric and gastroesophageal junction adenocarcinoma

artículo científico publicado en 2011

Potential for platinum analogs in the treatment of cancer of the uterine cervix

scientific article published on 01 September 1985

Pre-treatment tumor expression of ERCC1 in women with advanced stage epithelial ovarian cancer is not predictive of clinical outcomes: a Gynecologic Oncology Group study

artículo científico publicado en 2012

Preclinical and phase I studies of malonatoplatinum.

artículo científico publicado en 1980

Preclinical pharmacokinetics and stability of isophosphoramide mustard

artículo científico publicado en 1994

Preoperative concurrent paclitaxel-radiation in locally advanced breast cancer: pathologic response correlates with five-year overall survival

artículo científico publicado en 2010

Preoperative systemic chemotherapy followed by adjuvant postoperative intraperitoneal therapy for gastric cancer: a University of Southern California pilot program

artículo científico publicado en 1992

Preoperative twice-weekly paclitaxel with concurrent radiation therapy followed by surgery and postoperative doxorubicin-based chemotherapy in locally advanced breast cancer: a phase I/II trial

artículo científico publicado en 2003

Primary chemotherapy: concepts and issues

Primary large cell neuroendocrine carcinoma of the breast, a case report with an unusual clinical course.

artículo científico

Problems in the development of cytotoxic moieties linked to hormones

scientific article published on 01 August 1978

Proceedings of a GOG workshop on intraperitoneal therapy for ovarian cancer

artículo científico publicado en 2006

Proceedings of the Osteosarcoma Study Group Meeting (Bethesda, Maryland, January 19, 1977): introduction: treatment of osteogenic sarcoma

artículo científico publicado en 1978

Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study

artículo científico publicado en 2007

Progressive paresthesias after cessation of therapy with very high-dose cisplatin

artículo científico publicado en 1989

Prolonged topotecan infusion with cisplatin in the first-line treatment of ovarian cancer: an NYGOG and ECOG study

artículo científico publicado en 2005

Prospective evaluation of cardiotoxicity during a six-hour doxorubicin infusion regimen in women with adenocarcinoma of the breast

artículo científico publicado en 1985

Proteasome inhibition with bortezomib (PS-341): a phase I study with pharmacodynamic end points using a day 1 and day 4 schedule in a 14-day cycle

artículo científico publicado en 2005

Protracted drug infusions in cancer treatment: an appraisal of 5-fluorouracil, doxorubicin, and platinums

artículo científico publicado en 1993

Pulmonary effects of carmustine (bischloroethylnitrosourea, BCNU)

artículo científico publicado en 1979

Pulmonary toxicity after radiation and bleomycin: a review

artículo científico publicado en 1979

Pulmonary toxicity of antitumor agents

artículo científico publicado en 1983

Radiation-related eosinophilia. Correlation with delayed hypersensitivity, lymphocyte count, and survival in patients treated by curative radiotherapy

artículo científico publicado en 1975

Radiotherapy and chemotherapy in combined clinical trials: problems and promise

artículo científico publicado en 1978

Radiotherapy in the treatment of ovarian dysgerminoma

artículo científico publicado en 1988

Randomized trial: Another opinion ⬇️

artículo científico publicado el 1 de junio de 1992

Re: 'Radiation recall dermatitis induced by pegylated liposomal doxorubicin'

artículo científico publicado en 2004

Re: Prognosis and treatment of patients with breast tumors of one centimeter or less and negative axillary lymph nodes

artículo científico publicado en 2001

Recent updates in the clinical use of platinum compounds for the treatment of gynecologic cancers

artículo científico publicado en 2004

Relevance of chemotherapy dose and schedule to outcomes in ovarian cancer

artículo científico publicado en 2004

Repeated femoral vein cannulation for administration of chemotherapeutic agents

artículo científico publicado en 1983

Response to estramustine phosphate and paclitaxel in patients with advanced breast cancer: a phase I study.

artículo científico publicado en 1997

Reticulum cell sarcoma of the spinal epidural space

artículo científico publicado en 1971

Risk factors for doxorubicin-induced congestive heart failure

artículo científico publicado en 1979

Role of a nitrosourea (CCNU, NSC-79037) in advanced nonhematologic cancer

artículo científico publicado en 1974

Role of carboplatin in endometrial and cervical carcinomas

artículo científico publicado en 1992

Role of chemotherapy in head and neck cancer: systemic use of single agents and combinations in advanced disease

artículo científico publicado en 1980

Role of chemotherapy in the treatment of lung cancer: evolving strategies for non-small cell histologies

artículo científico publicado en 1984

Role of complement activation in hypersensitivity reactions to doxil and hynic PEG liposomes: experimental and clinical studies

artículo científico publicado en 2002

Saline MR peritoneography

artículo científico publicado en 1996

Salvage treatment of ovarian cancer ⬇️

artículo científico publicado el 1 de noviembre de 1997

Search for the optimal treatment of ovarian cancer: heavy metals, "belly baths," and ... yew trees ⬇️

artículo científico publicado el 1 de mayo de 1992

Second-look laparotomy for stage III epithelial ovarian cancer: rationale and current issues

artículo científico publicado en 1996

Selected anticancer drugs in Phase I trials in the United States (1979--1980).

artículo científico

Selection of cancer chemotherapy for a patient by an in vitro assay versus a clinician

artículo científico publicado en 1990

Seminoma and sarcoidosis: a cause for false positive mediastinal uptake in PET?

artículo científico publicado en 1998

Sequential methotrexate and 5-fluorouracil with bleomycin and cisplatin in the chemotherapy of advanced squamous cancer of the head and neck

scientific article published on 01 February 1986

Sequential single agents as first-line chemotherapy for ovarian cancer: a strategy derived from the results of GOG-132.

artículo científico publicado en 2003

Sequential therapy with INCAGN01949 followed by ipilimumab and nivolumab in two patients with advanced ovarian carcinoma

artículo científico publicado en 2020

Serial immunological parameters in a phase II trial of exemestane and low-dose oral cyclophosphamide in advanced hormone receptor-positive breast cancer

artículo científico publicado en 2017

Severe neurotoxicity from vinorelbine-paclitaxel combinations

artículo científico publicado en 1996

Simple and sensitive method for the quantitative analysis of lometrexol in plasma using high-performance liquid chromatography with electrochemical detection

artículo científico publicado en 1996

Single-dose dacarbazine and dactinomycin in advanced malignant melanoma

artículo científico publicado en 1985

Sounding board. Waiting for a bus: Does it explain age-dependent differences in response to chemotherapy of early breast cancer?

artículo científico publicado en 1978

Squamous cell carcinoma of the oral cavity in a woman with a 9-year history of ovarian cancer: is exposure to pegylated liposomal Doxorubicin a factor?

scientific article published on 25 March 2014

Squamous cell carcinoma of the oral cavity in nonsmoking women: a new and unusual complication of chemotherapy for recurrent ovarian cancer?

artículo científico publicado en 2012

Squamous cell carcinoma of the rectum: a consequence of immunosuppression resulting from inhibiting tumour necrosis factor (TNF)?

artículo científico publicado en 2016

Squamous cell carcinomas of the tongue and oral cavity as secondary malignancies: what factors are implicated?

artículo científico publicado en 2013

Stable disease in mesothelioma: a therapeutic achievement?

scientific article published on 01 January 2002

Staging of inoperable patients with bronchogenic carcinoma with special reference to bone marrow examination and peritoneoscopy

artículo científico publicado en 1972

Staging of testicular cancer: a proposed clinical-surgical schema

artículo científico publicado en 1980

Staging relationships and outcome in early stage testicular cancer: a report from the Testicular Cancer Intergroup Study

artículo científico publicado en 1991

Summary of investigations on platinum compounds and radiation interactions

artículo científico publicado en 1979

Supraventricular tachycardia and urticaria complicating leuprolide-induced ovarian suppression in a young woman with breast cancer: a case report

artículo científico publicado en 2013

Surgical adjuvant trials in the United States

artículo científico publicado en 1980

Surgical treatment for advanced epithelial carcinoma of the ovary

scientific article published on 01 September 1987

Synergistic activity of doxorubicin and the bisdioxopiperazine (+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane (ICRF 187) against the murine sarcoma S180 cell line

scientific article published on 01 March 1986

Systemic treatment of endometrial cancer: what is doxorubicin's role?

artículo científico publicado en 2014

Targeted agents and oxaliplatin-containing regimens for the treatment of colon cancer

artículo científico publicado en 2014

Targeted therapy: its status and promise in selected solid tumors part I: areas of major impact

artículo científico publicado en 2012

Targeted therapy: its status and promise in selected solid tumors. Part II: Impact on selected tumor subsets, and areas of evolving integration

artículo científico publicado en 2012

Targeting HER2 in ovarian and uterine cancers: challenges and future directions

artículo científico

Taxanes in adjuvant and neoadjuvant therapies for breast cancer.

artículo científico publicado en 1998

Temporal trends of subsequent breast cancer among women with ovarian cancer: a population-based study

scientific article published on 23 March 2020

Teniposide in adult solid tumors: a historical perspective

artículo científico publicado en 1992

Teniposide: overview of its therapeutic potential in adult cancers

artículo científico publicado en 1994

Testicular Cancer: Risk Factors and the Role of Adjuvant Chemotherapy

artículo científico publicado en 1980

Testicular cancer and the legacy of chemotherapy

artículo científico publicado en 1985

Testicular cancer: risk factors and the role of adjuvant chemotherapy

artículo científico publicado en 1980

The "other" asparaginase

scientific article published on 01 January 1976

The Benefits of Reducing My Hours to Half-Time (That Is, Three-Quarter Time)

artículo científico publicado en 2020

The Cancer Therapy Evaluation Program of the National Cancer Institute

artículo científico publicado en 1981

The biologic activity of MER-BCG in experimental systems and preliminary clinical studies

artículo científico publicado en 1977

The chemotherapy of Hodgkin's disease: past experiences and future directions

artículo científico publicado en 1978

The delta and epsilon errors in the assessment of cancer clinical trials

artículo científico publicado en 1979

The disposition of carboplatin in ovarian cancer patients

artículo científico publicado en 1988

The effect of germ-line BRCA mutations on response to chemotherapy and outcome of recurrent ovarian cancer

artículo científico publicado en 2014

The emerging roles of screening and prevention in women's cancer

artículo científico publicado en 2004

The evaluation of cytotoxic drugs

artículo científico publicado en 1979

The incidence of osseous involvement in lung cancer, with special reference to the development of osteoblastic changes

artículo científico publicado en 1973

The modulation of fluorouracil with leucovorin in metastatic colorectal carcinoma: a prospective randomized phase III trial. Gastrointestinal Tumor Study Group

artículo científico publicado en 1989

The prognostic value of pretreatment CA 125 in patients with advanced ovarian carcinoma: a Gynecologic Oncology Group study

artículo científico publicado en 2009

The rediscovery of DON (6-diazo-5-oxo-L-norleucine)

scientific article published on 01 January 1980

The regulation of MASPIN expression in epithelial ovarian cancer: association with p53 status, and MASPIN promoter methylation: a gynecologic oncology group study.

artículo científico publicado en 2011

The role of anthracyclines in the treatment of gastric cancer

artículo científico publicado en 1985

Therapeutic approaches in malignant mesothelioma

artículo científico publicado en 1977

Thoughts about September 11, 2001: civilization's resilience and tenacity

artículo científico publicado en 2002

Time relationship between last dose of daunorubicin and congestive heart failure

artículo científico publicado en 1977

Timing is everything: intraperitoneal chemotherapy after primary or interval debulking surgery for advanced ovarian cancer

artículo científico publicado en 2018

Tolerance and activity of oxaliplatin with protracted topotecan infusion in patients with previously treated ovarian cancer. A phase I study

artículo científico publicado en 2008

Tolerance of paclitaxel 3-hour infusion with and without granulocyte colony-stimulating factor on a biweekly schedule

artículo científico publicado en 1997

Tomudex (ZD1694, NSC 639186) in platinum-pretreated recurrent epithelial ovarian cancer: a phase II study by the Gynecologic Oncology Group

scientific article published on 01 January 1998

Topotecan continuous infusion: CA-125 responses including patients pretreated with other schedules of topotecan

scientific article published on 01 May 2006

Toxic effects of cis-dichlorodiammineplatinum(II) in man.

artículo científico publicado en 1979

Toxicity comparisons between two chemotherapy regimens as adjuvant or salvage treatment in nonseminomatous testicular cancer

artículo científico publicado en 1988

Trabectedin plus pegylated liposomal Doxorubicin in recurrent ovarian cancer.

artículo científico publicado en 2010

Trabectedin plus pegylated liposomal doxorubicin (PLD) versus PLD in recurrent ovarian cancer: overall survival analysis

artículo científico publicado en 2012

Treatment of Kaposi's sarcoma: overview and analysis by clinical setting

artículo científico

Treatment of advanced Hodgkin's disease with vinblastine (NSC-49842) or procarbazine (NSC-77213)

artículo científico publicado en 1969

Treatment of advanced refractory lymphoma with teniposide and lomustine

scientific article published on 01 February 1987

Treatment of breast cancer with medroxyprogesterone acetate

artículo científico publicado en 1968

Treatment of colon cancer based on biochemical modulation of fluoropyrimidines by hydroxyurea

artículo científico publicado en 1992

Treatment of early breast cancer, and reconstruction

artículo científico publicado en 1978

Treatment of epidemic Kaposi's sarcoma with a combination of interferon-alpha 2b and etoposide

artículo científico publicado en 1988

Treatment of epidemic Kaposi's sarcoma with etoposide or a combination of doxorubicin, bleomycin, and vinblastine.

artículo científico publicado en 1984

Treatment of liver metastases in patients with neuroendocrine tumors of gastroesophageal and pancreatic origin

artículo científico publicado en 2012

Treatment of malignant brain tumors with nitrosoureas

artículo científico publicado en 1971

Treatment of metastatic malignant melanoma with dacarbazine and cisplatin

artículo científico publicado en 1987

Treatment of non-small-cell lung cancer with vinblastine and very high-dose cisplatin. A Southwest Oncology Group study

artículo científico publicado en 1991

Treatment of patients with ovarian carcinoma with pegylated liposomal doxorubicin: analysis of toxicities and predictors of outcome.

artículo científico publicado en 2001

Treatment of primary breast cancer. Summary of the National Institutes of Health Consensus Development Conference

artículo científico publicado en 1980

Treatment of sarcomas: thinking out-of-the-box

artículo científico publicado en 2003

Treatment of small cell undifferentiated carcinoma of the lung: update of recent results

artículo científico publicado en 1980

Treatment strategies in relation to drug action

artículo científico publicado en 1987

Tuftsin - unimportant or forgotten

artículo científico publicado en 1977

Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study

artículo científico publicado en 2007

Two phase I dose-escalation/pharmacokinetics studies of low temperature liposomal doxorubicin (LTLD) and mild local hyperthermia in heavily pretreated patients with local regionally recurrent breast cancer

artículo científico publicado en 2014

Two-stage plans for patient accrual in phase II cancer clinical trials

artículo científico publicado en 1979

Use of medroxyprogesterone acetate in the treatment of Müllerian adenosarcoma: a case report

artículo científico publicado en 2002

Utility of endometrial sampling prior to risk-reducing hysterectomy in a patient with Lynch syndrome

artículo científico publicado en 2016

VM 26 and VP 16-213: a comparative analysis

artículo científico publicado en 1977

VM-26, a new anticancer drug with effectiveness in malignant lymphoma: an Eastern Cooperative Oncology Group Study (EST 1474).

artículo científico publicado en 1979

Vaccination with patient-specific tumor-derived antigen in first remission improves disease-free survival in follicular lymphoma

artículo científico publicado en 2011

Validation of the pharmacodynamics of BMS-247550, an analogue of epothilone B, during a phase I clinical study

artículo científico publicado en 2002

Vascular factors in acute pancreatitis.

artículo científico publicado en 1970

Visual abnormalities following nitrosourea treatment

artículo científico publicado en 1978

Vitamin A intoxication during taxol therapy for refractory ovarian cancer

artículo científico publicado el 16 de septiembre de 1992

We're "fossilized" in the optimal use of the Ommaya reservoir

artículo científico publicado en 1990

Weekly 5-fluorouracil combined with PALA: toxic and therapeutic effects in colorectal cancer

artículo científico publicado en 1987

Weekly paclitaxel with intermittent imatinib mesylate (Gleevec): tolerance and activity in recurrent epithelial ovarian cancer.

artículo científico publicado en 2010

Whatever happened to NSC--? An analysis of clinical results of discontinued anticancer agents.

artículo científico

Women's cancers: how the discovery of BRCA genes is driving current concepts of cancer biology and therapeutics

article

Working conference on mesothelioma treatment trials

artículo científico publicado en 1979

XIII International Charles Heidelberger Symposium and 50 Years of Fluoropyrimidines in Cancer Therapy Held on september 6 to 8, 2007 at New York University Cancer Institute, Smilow Conference Center

artículo científico publicado en 2009

[Platinum antitumor complexes].

artículo científico publicado en 2015

m-AMSA and PALA: two new agents in cancer chemotherapy

artículo científico publicado en 1979

m-AMSA: a new anticancer agent

scientific article published on 01 January 1980

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda